Andrew V Kossenkov

Title: Innovations in Lung Cancer Diagnosis by Andrew V Kossenkov

Introduction

Andrew V Kossenkov is a notable inventor based in Huntington Valley, Pennsylvania. He has made significant contributions to the field of cancer diagnostics, particularly focusing on lung cancer. With a total of three patents to his name, Kossenkov's work is at the forefront of medical innovation.

Latest Patents

Kossenkov's latest patents include groundbreaking methods for diagnosing lung cancers using gene expression profiles. One of his patents outlines compositions and methods for diagnosing lung cancer in a mammalian subject by utilizing a gene expression profile derived from the blood of the subject. This profile is characterized by the presence of seven or more selected genes. Another significant patent focuses on biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung diseases. This method employs micro-RNA expression levels to differentiate between healthy subjects and those with conditions such as chronic obstructive pulmonary disease (COPD) or non-small cell lung cancer (NSCLC).

Career Highlights

Kossenkov is affiliated with The Wistar Institute of Anatomy & Biology, where he conducts his research. His work has been instrumental in advancing the understanding of lung cancer diagnostics and treatment. His innovative approaches have the potential to improve patient outcomes significantly.

Collaborations

Kossenkov collaborates with esteemed colleagues, including Michael Showe and Louise C Showe. These partnerships enhance the research efforts at The Wistar Institute and contribute to the development of effective diagnostic methods.

Conclusion

Andrew V Kossenkov's contributions to lung cancer diagnostics through his innovative patents are paving the way for advancements in medical science. His work exemplifies the impact of research and collaboration in the fight against cancer.